
QMS Medical Allied Services Secures Five-Year Exclusive Distribution Agreement with Global Diagnostic Player HEINE Optotechnik
QMS Medical Allied Services Limited, an integrated healthcare solutions company, has signed an exclusive five-year agreement with HEINE Optotechnik, a globally reputed provider of primary diagnostic instruments. This partnership is set to significantly boost QMS's product business through the establishment of pan-India distribution capabilities.The exclusive agreement dictates that QMS will serve as the sole distributor in India for HEINE for the next five years, beginning on January 1, 2027.
Key Details of the Partnership
The contract products include a comprehensive range spanning General Medicine and ENT Instruments, Dermatoscopes and Digital Documentation, Ophthalmic Instruments, Laryngoscopes, Loupes and Headlights, Veterinary Diagnostic Instruments, Power Sources, Bulbs, Cases, Spare parts, and various special products.The agreement ensures that HEINE shall not appoint or supply any other distributor, dealer, or commercial partner for the sale or distribution of these products in India, directly or indirectly.
Financially, HEINE recorded net revenues from India of 2.6 million Euros, equivalent to approximately Rs. 30 crore, in calendar year 2026. The company projects that this turnover will increase to Rs. 70 crore by 2031, driven by the expanded partnership.
Strategic Implications for QMS
Mr Mahesh Makhija, Chairman and Managing Director of QMS Medical Allied Services Limited, commented on the partnership, stating, "We are thrilled to welcome HEINE Optotechnik to the QMS family. The exclusive partnership is central to our product business expansion strategy and will help us accelerate our growth trajectory over the next five years. Besides, this collaboration will open more doors for the company to capitalise on its wider presence and established reputation in a fast-growing Indian healthcare space."QMS is noted as India's only listed company demonstrating a presence and market share in the preventive healthcare management and pharma marketing segments. The company currently serves over 10 lakh patients and has partnered with more than 50 leading pharmaceutical and healthcare companies across India. QMS has set an ambitious target of surpassing Rs. 500 crore revenue by FY29.
About HEINE Optotechnik
HEINE Optotechnik, which began operations in 1946, stands as one of the world's leading manufacturers of primary diagnostic instruments. The company maintains manufacturing facilities in Germany, blending decades of expertise with modern manufacturing technologies. HEINE is represented in over 120 countries globally, with subsidiaries in the US, Canada, Australia, and Switzerland. The enterprise is entirely family-owned and employs 500 personnel.QMS Medical Allied Services is an integrated healthcare solutions company offering services that include patient engagement, Patient Service Programs (PSPs), disease management, preventive healthcare initiatives, and diagnostic solutions. Through its integrated approach, QMS helps pharmaceutical companies, healthcare providers, and patients improve continuity of care and enhance healthcare outcomes.
QMSMEDI Stock Price Movement
As of 12:06 PM, shares of QMS Medical Allied Services Limited are rallying to ₹153.80, gaining 0.70% in live market trading. The stock achieves its 52-week high and this surge is supported by a volume of 21,022 shares traded so far today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.